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List of Abbreviations 
 
AQoL-8D Australian Quality of Life questionnaire, version 8D 
BMI Body Mass Index (kg/m2) 
CONSORT Consolidated Standards of Reporting Trials 
CTF Clinical Test Forms 
GCT Glucose Challenge Test 
GDM Gestational Diabetes Mellitus 
GGT DPP Greater Green Triangle Diabetes Prevention Program 
GGT UDRH Greater Green Triangle University Department of Rural Health 
GP General Practitioner 
HAPA Health Action Process Approach 
MAGDA Mothers After Gestational Diabetes in Australia 
MMS Multimedia Messaging Service 
MSPSS Multidimensional Scale of Perceived Social Support 
NHMRC National Health and Medical Research Council 
NDSS National Diabetes Services Scheme 
NGDR National Gestational Diabetes Register 
OGTT Oral Glucose Tolerance Test 
PICF Project Information and Consent Form 
PHQ9 Patient Health Questionnaire, nine-question 
SPSS Statistical Package for Social Sciences 
T1DM Type 1 Diabetes Mellitus 
T2DM Type 2 Diabetes Mellitus 
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Background and rationale 
There are about a million Australians currently diagnosed with diabetes, most (85%) with type 2 
diabetes (T2DM).1 Local and international data suggest that about a third to a half of people with 
diabetes remain undiagnosed.2-4 More than half of the population in Australia is overweight or obese, 
which puts them at higher risk of T2DM. Diabetes is associated with a wide range of macrovascular 
and microvascular complications, including blindness, amputations, renal disease, and 
cardiovascular diseases. Currently AU$1.5 billion or 2.3% of the health budget was spent on 
diabetes.5 It is projected that by 2033 T2DM will pose an economic burden of AU$8 billion, with a 
436% increase in projected expenditure compared to 2002-3.1 This projected increase was driven by 
demographic factors, increase in obesity prevalence, extra services per case, and currently 
untreated diabetes.6 
GDM is defined as any degree of glucose intolerance with onset or first diagnosis during pregnancy.7 
About 10-13% of all pregnancies in Australia are complicated by GDM.8 Pregnancies with GDM are 
more likely to have adverse outcomes, including macrosomia, perinatal mortality, preeclampsia and 
caesarean delivery.9 Children born to mothers with GDM are also at increased risk of obesity, 
abnormal glucose metabolism and cardiovascular diseases later in life.10 About 30-84% of GDM 
patients re-develop the condition in subsequent pregnancies.11 One of the most significant long-term 
health impacts of GDM is the significantly increased risk of developing T2DM. The greatest increase in 
the incidence of type 2 diabetes following GDM occurs within the first five years, with up to 50% of 
women with prior GDM developing T2DM within this timeframe.11 As a young, at-risk group for T2DM, 
women with prior GDM represent a great opportunity for public health intervention in T2DM prevention. 
In many cases T2DM is a preventable disease. Studies have consistently shown that dietary 
modification along with moderate physical activity reduces the incidence of diabetes in high-risk 
populations.12,13 Lifestyle intervention has also been shown to reduce the development of diabetes in 
women who had GDM (averaging 12 years from index pregnancy) by 50%.14 
Lifestyle interventions targeting postpartum women face the challenge of retention and engagement. 
In the postpartum period, the infant’s needs pose a high demand on the mother’s energy and time15, 
which could affect the mother’s ability to participate in a lifestyle program and to engage with the 
study requirements. Family commitments, such as being married or partnered and having children in 
the household, have been identified as predictors of attrition in lifestyle interventions16,17. For those 
successfully retained, poor engagement or attendance could still result in a non-significant outcome 
despite the number of sessions offered.18 Differences in retention and engagement across the 
studies may have contributed to the wide range of effectiveness seen in lifestyle interventions in this 
group.19-22 
 
HISTORY OF DIABETES PREVENTION IN AUSTRALIA 
The Australian Government funded the Greater Green Triangle Diabetes Prevention Program (GGT 
DPP) to study the effectiveness and feasibility of identification of those at high risk, using a six-session 
group intervention in primary care. From waist circumference changes, it is estimated that the GGT 
DPP reduced the risk of developing diabetes by 40% and cardiovascular disease by 16%.23 The 
results of this project were used to inform the National Chronic Disease Strategy resulting in the 
recommendation of diabetes prevention to the Council of Australian Governments in 2007. Victoria 
has led the way with the Life! program, a  group-based intervention based on the GGT DPP. 
In 2012, the NHMRC-funded Mothers After Gestational Diabetes in Australia (MAGDA) study 
evaluated a group-based intervention for post-GDM women, but found that there were barriers to 
attendance at the intervention, such as childcare and travel. As it was delivered in a group setting, it 
was difficult to address individual needs, such as tailoring sessions for cultural differences. 
Telephone-based interventions have been shown to be effective in producing and maintaining 
lifestyle changes.24 The Australia's Get Healthy Information and Coaching Service® launched by the 
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New South Wales government in 2009 provided telephone coaching services which resulted in 
significant improvements in body weight, waist circumference, fruit and vegetable intake, and physical 
activity.25 A more recent telephone-delivered lifestyle intervention targeting Australian primary care 
patients with type 2 diabetes also demonstrated effectiveness in weight loss and increase in physical 
activity.26 
TeleMAGDA, a telephone-delivered lifestyle intervention for diabetes, may suit postpartum mothers 
as it addresses some of their barriers to lifestyle intervention, such as need for childcare and lack of 
time.27 Delivering lifestyle intervention via telephone could also be more cost effective than group-
based interventions.28 
Work on the TeleMAGDA project was funded through CRE Extension funding provided in 2015 by 
the Department of Health through the Australian Primary Health Care Research Institute. 
 
STUDY DESIGN 
The TeleMAGDA pilot is a single-arm implementation trial with no randomisation and no controls. 
Thirty three participants were recruited in Victoria and South Australia via the National Gestational 
Diabetes Register and through existing consented women in the MAGDA study control arm. 
The objectives of the pilot were to determine, 
 The feasibility of delivering a telephone-based lifestyle intervention for postpartum women with 
a history of gestational diabetes 
 The participation/attrition rate of the intervention 
 The acceptability of telephone-based MAGDA among postpartum mothers. 
 
TeleMAGDA was a pilot nested within the MAGDA study and was covered by the MAGDA study’s 
ethics approval from the Human Research Ethics Committees of Flinders and Deakin Universities. 
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Methods 
 
SELECTION AND RECRUITMENT 
Recruitment 
Participants were recruited from the following sources, 
 The MAGDA Study – via phone contact or discussion at final MAGDA testing session 
o Women from MAGDA’s NDSS (National Diabetes Services Scheme) NGDR (National 
Gestational Diabetes Register) mail-out who live to far away to attend MAGDA group 
sessions 
o MAGDA control participants who had completed their involvement in the MAGDA study 
o MAGDA participants who were unable to attend due to distance, and 
o MAGDA women in the intervention group who were not able to join any of the groups 
offered to them. 
 NDSS/NGDR mail out: A letter and a TeleMAGDA information brochure (with contact 
details for the study) sent out to women registered with the National Gestational Diabetes 
Register and living in a regional / rural area of western Victoria. 
 MAGDA website: An invitation to participate on the website where women could fill in their 
contact details to express their interest in being contacted by the research team for a 
detailed explanation.  
Inclusion and exclusion criteria 
Inclusion criteria 
 Diagnosed GDM in the last pregnancy (fasting glucose ≥ 5.5 mmol/L or 2-hr fasting glucose 
≥ 8.0 mmol/L on a 75g oral glucose tolerance test (OGTT)) or a glucose-challenge test (GCT) 
≥12.0 mmol/L. 
 Post-natal OGTT does not show T2DM (fasting glucose ≥ 7.0 mmol/L or 2-hr glucose ≥ 11.1 
mmol/L) 
 Residing in Victoria or South Australia 
 Between three and 24 months post-partum 
Exclusion criteria 
 Established diabetes (T1DM or T2DM) 
 Cancer (not in remission) 
 Severe mental illness in the last three months 
 Substance abuse (illicit drugs) in the last three months 
 Myocardial infarction in the last three months 
 Difficulty with English 
 Pregnant at any time during the study (from baseline to follow up data collection) 
 Surgical or medical intervention to treat obesity 
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Recruitment procedures 
Screening 1 
Following expression of interest in the study, the TeleMAGDA recruiter screened for eligibility over 
the phone. If eligible, the recruiter reviewed the TeleMAGDA consent form with the participant and 
obtained verbal consent. The consent form was distributed to the women along with the 
questionnaires and CTF (Clinical Test Forms), in the format selected by participant (paper or online). 
Data collected at this stage: 
 Antenatal and postnatal OGTT results (patient or GP report)  
 Verbal consent 
 Written consent 
 Eligibility (inclusion/exclusion criteria) 
If the consent form, questionnaires and CTF were not received within one week, the TeleMAGDA 
recruiter contacted the woman to encourage return of the documents. 
 
 
 
 
Recruiter contacted the woman to provide more  
information and answered any questions 
 
 
 
 
Not interested. Asked why. 
 
 
 
If interested, checked eligibility 
Recruiter asked questions on 
diabetes status, cancer, 
severe mental illness, 
substance abuse, myocardial 
infarction, proficiency in 
English, Antenatal and 
postnatal OGTT results. 
 
 
No further 
contact 
 
If eligible, recruiter provided the PICF, 
questionnaires and data collection pack 
 
 
 
 
Figure 1: Recruitment Flowchart 
 
 
 
 
Two methods of recruitment were employed. 
Participant attended Baseline 
data collection (T1) 
Not eligible. No further contact 
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REPORTING 
The TeleMAGDA trial reported according to the CONSORT (Consolidated Standards of 
Reporting Trials) 2010 Statement (http://www.consort-statement.org). 
 
STUDY INTERVENTION 
Theoretical framework 
The theoretical framework of this intervention is based on the Health Action Process 
Approach (HAPA) and self-regulation theory.29,30 Several other theories, strategies and 
constructs are incorporated into the design of the intervention. These include the social 
learning theory,31,32  empowerment-oriented counseling,33-35 goal-setting approach,36,37  
self-efficacy and self-evaluation.21,29 
The HAPA model (figure 2) was developed by Ralph Schwarzer (http://www.hapa-model.de/.). 
 
 
 
 
 
Figure 2: HAPA model 
 
 
The Health Action Process Approach suggests that the adoption, initiation, and 
maintenance of health behaviours must be explicitly conceived as a process that 
consists of at least a motivation phase and a volition phase. The latter might be further 
subdivided into a planning phase, action phase, and maintenance phase. It is claimed 
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that perceived self-efficacy plays a crucial role at all stages along with other cognitions. 
For example, risk perceptions serve predominantly to set the stage for a contemplation 
process early in the motivation phase but do not extend beyond. Similarly, outcome 
expectancies are chiefly important in the motivation phase when individuals balance 
the pros and cons of certain consequences of behaviours, but they lose her predictive 
power after a personal decision has been made. However, if one does not believe in 
one's capability to perform a desired action, one will fail to adopt, initiate and maintain 
it. 
The MAGDA Diabetes Prevention Program was a community-based group intervention. To 
ensure program fidelity, all coaches received one-day training on the content and style of the 
intervention as well as ongoing support. The theoretical framework for this intervention 
included HAPA and self-regulation theory.  As consistent with population-based diabetes 
prevention programs 13,39 the five goals of MAGDA were weight control, reducing total energy 
intake, reducing fat intake to no more than 30% energy from fat, reducing saturated fat intake 
to no more than 10% energy from saturated fat, increasing fibre intake to at least 15g/1000 
kCal, and increasing physical activity to at least 30 minutes/day of moderate intensity physical 
activity. The modification to adapt to a telephone delivery of the sessions in TeleMAGDA 
included decreasing the session duration from two hours to 30 minutes per session. 
The TeleMAGDA intervention is an adaptation of the MAGDA intervention where the program 
structure and materials were adapted to be delivered by phone over seven sessions.39 
TeleMAGDA participants were given a handbook which covered each of the intervention 
goals, and homework and activities to be discussed during the telephone sessions. Apart from 
the first introductory session, participants could choose the order of topics to be covered in the 
sessions. Goal setting, barriers identification, problem solving and reflection on progress were 
an integral part of the program at every session. Women were also given self-monitoring 
diaries to track their progress. 
 
Materials 
Participant Handbook 
The handbook was a self-help manual for the participants. It provided information on the 
study and introduced the intervention goals along with strategies to achieve them. This 
material helped to keep the telephone session short and manageable (20-30 mins), while 
still building the same range of skills in the participants as they would receive in a 2-hour 
individual session. Each chapter consisted of a series of short articles which were 
developed specifically to engage postpartum women. The articles described the significance 
of the intervention goals to their health and provide the knowledge required to achieve that 
goal, e.g. types of fat and fibre and their food sources, the science of energy balance, the 
concept of energy density, portion sizes, glycemic index, the amount of fibre, fat and energy 
in common food items, the amount of sleep a baby needs, sleep-training techniques, ways 
to relieve stress, identifying anxiety and depression. 
Practical tips were included throughout the manual to address the physical, mental, 
emotional and social needs of postpartum women, e.g. having a high-fibre breakfast with 
protein to keep the energy up, making baby and toddler-friendly family meals, finding time to 
eat instead of multi-tasking, make and freeze baby-friendly meals, not to worry about 
competing baby’s developmental milestones with other mums, or making time to do 
something fun with partner. 
Skills required for lifestyle modification were also included in the manual, e.g. ingredients 
substitution, recipe modification, food label reading, choosing healthy take-away choices. 
These skills were reinforced through homework and activities at the end of each chapter. 
The participant read a chapter and completed the homework and activities at the end of the 
chapter in preparation for the upcoming session. 
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During the telephone session, the coach referred to the Participant Handbook to address 
any knowledge gap and to go through the answers for the homework with the participants. 
Coach Manual 
The coach manual provided an overview of the study and the intervention sessions. It 
described the structure of calls and ways to facilitate goal-setting and problem-solving (see 
excerpt below). Suggested scripts for the telephone sessions were also included. Homework 
and other important points of discussion were included. The section on Session Guides 
provided an outline of each telephone session on a single page for the coach to refer to 
during the telephone session. 
Participant Casebook 
The casebook was a data tracking instrument to be filled in by the coaches. It collected 
process data, such as the attempts of calls, time and duration of calls. It also recorded 
personal information on the participants such as their perceived risks, previous goals, 
perceived barriers, which helped the coach to provide continuous care to the participants. 
Delivery 
The intervention was administrated by trained health care professionals. All facilitators were 
provided with a manual and a one-day training session by an experienced researcher in 
telephone-based intervention. The training included motivational interviewing skills, effective 
communication skills, goal setting and problem solving and role play of the telephone 
sessions. 
After the baseline results and questionnaires were received by the research team, the 
participant was sent a participant handbook. Participants were asked to complete a series of 
seven sessions, all carried out at two week intervals, with a maximum of four weeks between 
sessions. Each telephone session was aimed to run for approximately 30 minutes. 
Intervention goals 
There have been successful implementation trials for diabetes prevention in Finland38 and 
Australia.13 Evidence-based goals used in the GGT UDRH Life! program, the Melbourne 
Diabetes Prevention Study, and the MAGDA study were used in TeleMAGDA: 
1. Reduce fat intake (no more than 30% of energy from fat) 
2. Decrease saturated fat intake (no more than 10% of energy from saturated fat) 
3. Increase fibre intake (at least 15g/1000kCal per day) 
4. Increase physical activity (at least 30 minutes of moderate exercise per day) 
5. Reduce body weight (at least 5% of body weight within 12 months) 
 
Intervention topics 
The first session was about establishing the participants’ reasons to be in the program and 
addressed their risk perception. The last session (session 7) was about maintaining the 
changes in the long term. Sessions 2 to 6 introduced the five intervention goals for diabetes 
prevention. These goals could be delivered in any order, depending on the participant’s 
choice. 
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  Table 1 TeleMAGDA session topics 
Session Content 
Session 1 Establishing why she wants to be in the program 
Her risks of developing diabetes 
Introduction to the TeleMAGDA goals 
Setting a physical activity goal 
Session 2 Fat and saturated fat 
Review and set physical activity and healthy eating goals 
Session 3 Weight Management 
Review and set physical activity and healthy eating goals 
Session 4 Fibre 
Review and set physical activity and healthy eating goals 
Session 5 Exercise 
Review and set physical activity and healthy eating goals 
Session 6 Sleep, stress and depression 
Review and set physical activity and healthy eating goals 
Set goals on sleep, stress and/or depression 
Session 7 Lapses and relapses, rewards 
Long term goal setting 
 
Adherence assessment 
Participant completion of each telephone session was recorded and a continuous analysis 
kept. Program completers were defined as those women who completed five or more 
telephone sessions. Achievement of the five goals from changes over the length of program 
was measured in the study questionnaire data and the CTF. 
 
STUDY PROCEDURES 
Baseline Assessments (Time 1, T1) 
 Fasting Capillary Blood Glucose reading using Glucometer (Finger Prick) 
 Anthropometric measurements. 
o Height 
o Weight 
o Waist Circumference 
o Hip Circumference 
 Blood Pressure (two measures one minute apart; if difference in systolic between both 
measures >10mmHg or diastolic >6mmHg, a third measure was taken) 
 Questionnaires 
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Completion/Final data collection (Time 2) 
After the final telephone session 
 Fasting Capillary Blood Glucose reading using Glucometer (Finger Prick) 
 Anthropometric measurements. 
o Weight 
o Waist Circumference 
o Hip Circumference 
 Blood Pressure (two measures one minute apart, if difference in systolic between both 
measures >10mmHg or diastolic >6mmHg, a third measure was taken) 
 Questionnaires 
Data collection was conducted by the participant’s GP. The participants recruited in the 
regional / rural area attended a local pharmacy for data collection. Participants had the 
option of completing the questionnaire by pen and paper, with included reply paid post 
envelope, email web surveys link or via the MAGDA website. 
Data collection 
 
Table 2. Schedule for Data Collection 
Assessment Screening 1 
 
Baseline (T1)  Follow up (T2) 
Exclusion Criteria x x x 
Informed Consent x   
Results of antenatal and postnatal 
OGTT 
x   
Capillary Fasting Glucose  
x x 
Anthropometric Measurements   x x 
Blood Pressure  x x 
Demographics  x  
Health Status  x x 
Food Frequency Questionnaire  
x x 
The Active Australian Questionnaire 
 x x 
Diet and Physical Activity self-
regulation (based on the Treatment 
Self-Regulation Questionnaire) 
 x x 
Quality of Life (AQoL-8D)  
x x 
Risk Perception   x x 
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Psychological wellbeing (PHQ9)  
x x 
Social Support (Multidimensional 
Scale of Perceived Social 
Support) 
 x x 
 
Feasibility and attendance data 
An exit survey was conducted with all participants following their completion of the study, 
including those who withdrew before completion. 
Attendance data were collected from the relevant casebooks. 
Cost 
To measure the total cost of delivering the intervention, the cost of intervention materials, 
personnel and time were recorded. 
Health care usage of participants over the time they were involved in the program (minimum 
three months) was collected during the exit interview.  
 
DATA COLLECTION 
Data collection forms 
Online and paper based forms were used to collect information. 
The clinical measurements were recorded by the GP/pharmacist on the CTF, with 
questionnaires containing self-reported information. CTFs were returned to the research 
team via post, fax, email or MMS. Only the participant ID was recorded on all forms, with the 
exception of the patient demographic questionnaire SECTION A-1 which contains 
participants’ contact details. 
Web-based surveys 
Health Surveys was used to develop the online questionnaire as it had been used for the 
Melbourne Diabetes Prevention Study and for MAGDA. The questionnaire was slightly 
modified from the MADGA questionnaire but retained all the same information for 
collection. 
Only the study team had access to the data stored in the online survey. Data collected on 
the paper questionnaire were manually entered into Health Surveys. 
All data are stored on Deakin University eSolutions servers, which are ISO 9000 compliant 
for data security and access and quality control. 
Data management 
Paper forms returned to the research assistant are stored in a locked cupboard in a locked 
room at Deakin University, Burwood. At the end of the data collection period, the online data 
were exported from Health Surveys and saved as a read-only file in the study team’s share 
drive at Deakin University. Access is only available for the study team and is password 
protected. 
 
QUALITY ASSURANCE 
Data Collection 
The Data Collection Forms contained easy-to-read instructions about performing data 
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collection alongside required measurements. 
Intervention 
Sessions were audio recorded for audit purposes using a uni-directional microphone. 
Recordings are stored securely on the research team’s share drive at Deakin University. 
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Results 
All statistical procedures were performed using SPSS Version 22. Baseline-carried-forward 
was used to treat missing data. Differences in characteristics, between engaged and non-
engaged participants, between completers and non-completers, and the relationship between 
continuous outcomes and categorical demographic factors were assessed using independent 
sample t-tests. Weight change (kg) was assessed using paired t-tests. Levene’s tests were 
used to assess the equality of variances between groups. If variances were significantly 
different between groups, t-tests assuming unequal variances (Satterthwaite equation) were 
used. Categorical variables between the groups were assessed using 𝜒2 tests. The 
relationship between continuous and continuous psycho-social variables were assessed using 
Pearson’s correlation tests. 
Qualitative data from the structured interviews were manually coded for common themes by 
the first author, which was reviewed by the co-author. The themes were presented as a 
frequency distribution. Quantitative results were presented as means with standard deviations. 
Statistical significance was accepted at p < 0.05.  
Tables 3 to 9 and Figure 4 present the results of the pilot study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: TeleMAGDA CONSORT Diagram 
  
Assessed for eligibility (n=86) 
 
Excluded (n=37) 
   Not meeting inclusion criteria (n= 9) 
   Declined to participate (n=28) 
Withdrawn (n=20) 
 Time (5) 
 Pregnant (1) 
 Lost to contact (14) 
Started intervention (n=33) 
 
Completed post-intervention testing (n=19) 
 
Eligible to participate (n= 53) 
Completed all sessions (n=25) 
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Table 3: Baseline characteristics of participants in TeleMAGDA 
 Mean (SD) 
Age  34.75 (4.80) 
BMI 29.37 (5.96) 
Fasting Blood Glucose (N=30) 4.95 (0.493) 
 N (%) 
Marital Status   
Married 24 (73) 
Single 1 (3) 
De-Facto 7 (21) 
Not Recorded 1 (3) 
Highest Level Of Education   
Secondary Education 2 (6) 
Certificate Level 7 (21) 
Diploma Level 3 (9) 
Bachelor Degree 11 (33) 
Masters Degree 7 (21) 
Doctoral Degree 1 (3) 
Not Recorded 2 (6) 
Family Income Level   
Low 4 (12) 
Medium 16 (49) 
High 12 (36) 
Country Of Birth   
Australia 18 (55) 
Other 14 (42) 
Not Recorded 1 (3) 
Number Of Children   
1 11 (33) 
2 14 (42) 
3 4 (12) 
4 3 (9) 
Not Recorded 1 (3) 
 
Table 4: Characteristics of postpartum women in diabetes prevention program by engagement 
level (completion of 7 sessions) 
 Engaged 
(n=25) 
Non engaged 
(n=8) 
p-value 
 Mean (SD) Mean (SD)  
Age, years 35.45 (4.21) 35.91 (6.95) p=0.819 
BMI, kg/m
2 
27.96 (4.94) 34.41 (6.94) p=0.009 
Depression (PHQ9) 12.80 (3.53) 12.57 (3.41) p=0.880 
Quality of life (AQOL-8D) 0.77 (0.15) 0.82 (0.20) p=0.543 
Self-regulation (Relative autonomous score) 33.6 (16.9) 25.5 (18.3) p=0.304 
Social support (MSPSS) 5.98 (0.64) 5.95 (1.21) p=0.944 
Average session duration, minutes 26.8 (5.5) 33.8 (8.7) p=0.014 
Number of sessions received 7.0 (0.0) 3.1 (2.2) p<0.001 
Frequency of staff contact to organise each 
session 
1.9 (0.8) 5.5 (2.9) p=0.019 
Time taken for staff to organise each session, 
minutes 
3.4 (1.5) 9.0 (3.7) p=0.007 
  
18  
Table 5: Characteristics of postpartum women in diabetes prevention program by retention 
(provided final measurement) 
 Completers 
(n=19) 
Non completers 
(n=14) 
p-value 
 Mean (SD) Mean (SD)  
Age, years 35.49 (4.45) 35.67 (5.61) p=0.188 
BMI, kg/m
2 
27.21 (4.93) 32.15 (6.17) p=0.017 
Depression (PHQ9) 13.11 (3.84) 12.23 (2.86) p=0.491 
Quality of life (AQOL-8D) 0.74 (0.18) 0.84 (0.13) p=0.085 
Self-regulation (Relative autonomous score) 33.5 (15.8) 29.8 (19.6) p=0.559 
Social support (MSPSS) 5.81 (0.85) 6.24 (0.62) p=0.152 
Average session duration, minutes 28.03 (5.10) 28.87 (8.98) p=0.763 
Number of sessions received 6.9 (0.3) 4.9 (2.6) p=0.003 
Number of staff contact to organise each session 2.0 (0.9) 3.7 (2.9) p=0.061 
Time taken for staff to organise each session, 
minutes 
3.75 (1.90) 6.00 (4.10) p=0.085 
Number of staff reminders to attend GP clinic 1.0 (1.3) 1.4 (1.3) p=0.445 
 
Baseline characteristics Mean Standard 
deviation 
Age (n=32) 34.75 4.80 
Fasting blood glucose (n=30) 4.95 0.49 
Weight (n=33) 77.01 16.54 
BMI (n=32) 29.37 5.96 
Systolic blood pressure (n=33) 114.23 10.76 
Diastolic blood pressure (n=33) 74.12 10.44 
Waist (n=33) 91.18 13.79 
Hip (n=33) 106.69 12.63 
Waist to Hip Ratio (n=33) 0.85 0.06 
Risk of developing Type 2 diabetes by 60 years of age (%) 
(n=28) 
40.89 26.88 
Modifiable component of Type 2 diabetes risk (%) (n=27) 26.59 21.51 
 
 
Table 6: Session Times 
 N Minimum Maximum Mean Std. Deviation 
Time Contact per session 
(Session duration, min) 
32 18.14 53.00 28.37 6.82 
Time Admin per Session  
(Time taken to organise 
for each session, mins) 
32 1.00 15.00 4.66 3.14 
Total Time per session 
(Total staff time for 
session delivery per 
session), min 
32 20.86 68.00 33.03 9.02 
Admin Contact per 
Session (Contact 
frequency to organise 
each session, min 
32 .86 9.33 2.42 1.74 
Total Admin time (Time 
taken to organise 
sessions per participant, 
mins) 
33 6.00 57.00 24.48 11.27 
Total contact Time (Total 
session delivery time per 
participant, mins) 
33 .00 243.00 166.39 59.65 
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 N Minimum Maximum Mean Std. Deviation 
Time Admin plus Contact 
(Total staff time for 
session delivery per 
participant, mins) 
33 6.00 277.00 190.88 64.13 
Total Admin Contact 
(Number of contacts to 
organise sessions per 
participant, n) 
33 4.00 28.00 12.79 5.85 
Total No Sessions per 
participants (n) 
33 .00 7.00 6.07 1.97 
Valid N (listwise) 32     
 
Table 7: Intervention Topics/Chapters 
Program 
contact time 
S1 Sleep Weight Fibre Fats Exercise S7 Total  
No. of session 32 27 28 29 30 30 27 203 
Total time 
(mins) 
1349 696 721 811 780 591 543 5491 
Average time 
per session 
(mins) 
42.16 25.78 25.75 27.97 26.00 19.70 20.11 171.59 
 Chapter covered  
Program Cost S1 Sleep Weight Fibre Fats Exercise S7 Total 
Cost 
Total program 
cost 
$1400.40 $722.72 $741.98 $842.01 $806.97 $604.42 $552.61 $5671.11 
Staff time $1222.14 $630.75 $646.70 $733.84 $703.90 $526.33 $480.86 $4945.52 
Telephone $178.26 $91.97 $95.28 $107.17 $103.07 $78.10 $71.75 $725.60 
Average per 
participant 
       $177.22 
Staff time        $154.55 
Telephone        $22.67 
Average per 
session 
$43.76 $26.77 $26.50 $29.03 $26.90 $20.15 $20.47  
 
Table 8: Time/Cost Feasibility 
Administration Contact 
Time 
No. Of Contact Contact Time 
(Mins) 
 
Total 416 809  
No. Of Participant 33 33  
Average per Participant  12.61 24.52  
    
Administration Cost Staff Time Telephone Cost Total Cost 
Total Cost $ 741.84 $ 84.65 $ 826.49 
No. Of Participants 33 33 33 
Average per Participant $ 22.48 $ 2.57 $ 25.05 
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Figure 4: Relationship between reminding contact and program session time 
 
 
 
 
Table 9: Preliminary efficacy 
Paired t-tests of study outcome measures. 
Outcome (unit; n) Difference Standard 
deviation 
95% CI 
Lower 
95% CI 
Upper 
p-value 
Weight (kg; 19) -1.97 3.98 -3.89 -0.06 0.044* 
BMI (kg/m
2
; 18) -0.82 1.68 -1.66 0.01 0.054 
Waist (cm; 19) -0.88 5.52 -3.54 1.77 0.494 
Hip (cm; 19) -2.61 2.93 -4.02 -1.19 0.001* 
Waist:Hip (cm; 19) 0.13 0.05 -0.01 0.04 0.282 
Systolic blood pressure (mmHg; 
19) 
-0.52 9.43 -5.07 4.02 0.810 
Diastolic blood pressure (mmHg; 
19) 
4.23 11.19 -1.16 9.63 0.116 
Fasting plasma glucose (mmol/l; 
17) 
0.19 0.65 -0.14 0.53 0.236 
*Significant at α=0.05 
 
Proportion (%) of participants meeting the FIN DPS goals at baseline and T2.  
Goal Baseline T2 
No more than 30% energy from fat 2/30 (6.7%) 1/16 (6.2%) 
No more than 10% energy from saturated fat 1/30 (3.3%) 1/16 (6.2%) 
At least 15 g/1,000 kCal fibre intake 3/30 (10.0%) 3/16 (18.8%) 
At least 30 minutes/day moderate intensity 15/28 (53.6%) 10/16 (62.5%) 
At least a 5% reduction in body weight N/A 4/19 (21.0%) 
 
 
QUALITATIVE POST INTERVENTION 
Participant responses in qualitative, post intervention telephone interviews showed that the 
program provided a positive experience. Particularly useful aspects, as reported by the 
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participants, were program accessibility and flexibility (autonomy in deciding time of calls and 
program topic order), participant workbooks, fortnightly goal setting, ongoing problem solving 
with coach support, building a relationship with coach and being accountable for the goals. 
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Discussion 
Of the 86 women approached or who contacted the study team, 10% did not meet the 
eligibility criteria. A further 33% declined to participate. Of those eligible, 33 provided baseline 
measurements and were included in the study. Baseline characteristics of the participants are 
presented in Table 3. 
ACCEPTABILITY 
Almost all women (90%) found the program to be an overall positive experience, particularly in 
their interactions with the coaches. The most cited aspects of the program considered most 
useful in helping behavioural change were information in the handbook (37%), the goal setting 
component of the intervention (30%), and accountability to the coaches (17%). The most cited 
favourite aspect of the intervention was the telephone sessions (53%), followed by 
accountability (30%) and receiving support and motivation (27%). 
All but one participant saw the telephone intervention as the best fit with their lives, mainly due 
to accessibility and childcare needs. Telephone was also the preferred option when compared 
with the internet by many participants (37%). Some (30%) suggested at least one or two face-
to-face group sessions, mainly for peer interactions.  
The use of the internet was perceived to be a less effective form of communication, and being 
less engaging. This was also apparent with regard to the online questionnaires, particularly the 
post intervention follow up questionnaires, which were only completed by 58% of participants.  
Data collection proved more difficult, and required numerous reminders and ‘nagging’ from the 
research team to visit GP and to complete online surveys, more so at follow up. However, 
baseline measurements were completed as these were required before participants 
commenced the program. 
The website and forum were not found to be used by the participants, with 60% not visiting the 
website and only 17% posting questions/comments on the website forum. 
FEASIBILITY 
The average duration of each session was 28±7 minutes. On average, each session was 
costed at $28 per participant, which included staff time and the cost of telephone calls. The 
average cost of the program for each participant was $177 and an additional $25 was spent on 
organising the sessions. The total program cost for all participants was $5671, of which $4945 
was the staff time and $726 was the cost of the telephone calls, with additional $826 involved 
in organising sessions. 
The overall cost effectiveness of the program was not able to be determined as a control 
group was not included in this pilot study nor a proxy control in usual care to act as a 
comparison. Whether the intervention reduces participant’s health care resource usage was 
not able to be determined. 
Pushing low interest participants by putting more effort in encouraging them to complete the 
intervention did not help nor was it feasible. More reminding, by means of phone calls, SMS 
and email, and rescheduling, was required, but did not help to improve their exposure to the 
program. On average it took 13 scheduling contacts (telephone call, SMS or email) to deliver 
six sessions. Each participant was contacted 2.7±2.1 times (range 0.9-10.0) to schedule for 
each session, or a total of 13.9±6.1 times (range 4-28) to schedule sessions for the entire 
program. It took 4.7±3.1 min (range 1-15mins) to organise one session for each participant, or 
a total of 24.5±11.3 (range 6-57) minutes for the entire program per participant. 
Aside from the first session which were nearly double in duration compared to all the other 
sessions, there was no time-trend on increasing or decreasing staff time per session (including 
time to organise sessions) from the first to the last session. 
Only 15% required intervention sessions out-of-hours (after 5pm calls). A total of 47% of the 
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sessions were delivered between 8:30am and 1pm, 38% were delivered between 1pm to 5pm. 
Almost all sessions (97%, 199/205) were delivered on weekdays. 
PARTICIPATION RATE 
Of the 33 women recruited, 23 (70%) completed the program and 10 discontinued. Attendance 
to the program was high with 87% of participants receiving the program as scheduled. A total 
of 76% completed all seven sessions, with 82% completing at least six sessions. Attendance 
was well sustained throughout the intervention, from 97% attendance at Session 1 to 81% at 
Session 7. 
Engaged participants had lower BMI (28.0±4.9 vs 34.4±6.9 kg/m2, p=0.009), shorter session 
duration (26.8±5.5 vs 33.8±8.7 mins, p=0.014) and received less staff contact to organize 
each session (1.9±0.8 vs 5.5±2.9 contacts per session, p=0.019).  
With engagement effort defined as the total time taken to organise each session, those without 
a university degree required greater effort to engage (5.8±3.2 vs 3.5±1.5 minutes per session, 
p=0.014). Higher BMI was also associated with greater engagement effort (r=0.45, p=0.011). 
High engagement effort were significantly correlated with less sessions completed (r=-0.802, 
p<0.001). 
There was no significant relationship between engagement effort and age, household income, 
education level, number of children, self-regulation, perceived social support, depression and 
quality of life. 
Engaged and non-engaged participants did not differ in age, country of birth, household 
income, level of education, number of children, depression, quality of life, self-regulation, and 
social support. 
BARRIERS TO PARTICIPATION (REASONS FOR NON-
PARTICIPATION) 
Of those declining to participate in study at initial contact, refusal reasons included time, work, 
belief that they were not at risk and that their lifestyle is already healthy. 
The most common perceived barrier to the participating in the telephone coaching sessions 
included time constraints (27%), difficulty with childcare commitments (20%) and difficulty 
getting motivated (13%). 
ATTRITION RATE 
All 33 participants provided baseline clinical data from the GP clinic, but only 19 (58%) 
provided the final measurements from the GP clinic. 
With completers defined as those who provided the final body weight at the GP clinic. 
completers had lower BMI (27.21±4.45 vs 32.15±6.17, p=0.017) and received more sessions 
(6.9±0.3 vs 3.7±2.9, p=0.003). There was a trend for participants born outside of Australia 
being more likely to complete the final measurements compared to those born in Australia 
(79% vs 44%, χ2=3.802, df=1, p=0.05). 
Non completers had more reminders to attend GP clinic appointment, and received more staff 
contact to organise each phone sessions. Completers and non-completers did not differ in 
age, household income, education level, number of children, self-regulation, perceived social 
support, depression and quality of life. The small number of participants in this pilot prevents 
sub-group analyses to determine the effects of participant factors on engagement. However, 
the intervention attendance and engagement rates in this telephone-based lifestyle-
modification program were much higher than in the MAGDA face-to-face, group-based 
program. 
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Conclusion 
Group-based lifestyle-modification programs have been shown to be effective in delaying the 
progression to T2DM for the older population. This is not the case for post-partum women who 
had GDM during pregnancy, due to barriers for attendance, such as childcare and travel. It is 
also difficult to address individual needs in a group setting. Telephone-based interventions, 
however, can address these difficulties. TeleMAGDA examined whether a telephone-based 
intervention was feasible and acceptable to postpartum mothers. 
TeleMAGDA showed a strong fidelity to the program, with three quarters of participants 
completing all seven sessions. Almost all participants found that the program was a positive 
experience, with the telephone intervention giving the best fit to their lives. Telephone delivery 
is also a relatively inexpensive way of delivering a lifestyle-modification program, provided that 
participants have a strong interest in completing the full program. 
TeleMAGDA showed that delivering a diabetes-prevention program by telephone to 
postpartum women with a history of GDM is both feasible and acceptable, but the 
effectiveness of that program in reducing diabetes risk factors was not able to be determined 
due to the small sample size of the pilot. Further studies will be required. 
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